Comparison of Magnesium Values in Functional Constipation and Control Patients

Yıl 2025, Cilt: 9 Sayı: 3, 367 - 372, 22.12.2025

Arzu Gülseren , Emine Uçar

https://doi.org/10.46332/aemj.1649473

Öz

Purpose: The objective of this study was to compare serum magnesium levels in patients with functional constipation against a control group.

Materials and Methods: This retrospective study included patients diagnosed with functional constipation who presented to the pediatric gastroenterology outpatient clinic between 2021 and 2025. The diagnosis of functional constipation was based on the ROMA IV criteria.

Results: A total of 757 patients' data were analyzed. The functional constipation group comprised 479 patients, while the control group included 278 patients. No significant difference was observed between the mean ages of patients in the functional constipation group (9.4±4.3 years) and control group (9.1±4.0 years) (P=0.525). The mean serum magnesium level for patients with functional constipation was 2.0±0.1 mg/dL, which was comparable to the mean level in the control group (2.0±0.1 mg/dL) (P=0.631). However, mean serum calcium levels were significantly higher in the functional constipation group (9.2±0.3 vs. 9.4±0.4; P=0.001).Among the patients with functional constipation, 266 (55.5%) had not received treatment prior to this study, whereas 217 (44.5%) had received treatment. There were no significant differences in the values of hemoglobin, platelet count, calcium, magnesium, sodium, and chloride between treated and untreated patients.

Conclusion: It has been determined that magnesium and other electrolyte levels in patients with functional constipation are not different from those in the normal population. Prospective studies are needed to gain a more comprehensive understanding of the commonly seen functional constipation.

Anahtar Kelimeler

electrolytes , functional constipation , magnesium

Etik Beyan

This study has been approved by the Kayseri City Hospital Non-Interventional Clinical Research Ethics Committee (dated 28.01.2025, and numbered 300).

Fonksiyonel Kabızlık ve Kontrol Hastalarında Magnezyum Değerlerinin Karşılaştırılması

Öz

Amaç: Bu çalışmanın amacı fonksiyonel kabızlığı olan hastalarda serum magnezyum düzeylerini kontrol grubuyla karşılaştırmak amaçlanmıştır.

Araçlar ve Yöntem: Bu retrospektif çalışmaya 2021-2025 yılları arasında pediatrik gastroenteroloji polikliniğine başvuran fonksiyonel kabızlık tanısı almış hastalar dahil edildi. Fonksiyonel kabızlık tanısı ROMA IV kriterlerine göre belirlendi.

Bulgular: Toplam 757 hastanın verileri analiz edildi. Fonksiyonel kabızlık grubunda 479 hasta, kontrol grubunda ise 278 hasta vardı. Fonksiyonel kabızlık grubundaki hastaların ortalama yaşları (9.4±4.3 yıl) ile kontrol grubundaki hastaların ortalama yaşları (9.1±4.0 yıl) arasında anlamlı bir fark gözlenmedi (P=0.525). Fonksiyonel kabızlığı olan hastalarda ortalama serum magnezyum düzeyi 2.0±0.1 mg/dL idi ve bu değer kontrol grubundaki ortalama düzeye (2.0±0.1 mg/dL) benzerdi (P=0.631). Ancak, ortalama serum kalsiyum düzeyleri fonksiyonel kabızlık grubunda anlamlı derecede daha yüksekti (9.2±0.3'e karşı 9.4±0.4; P=0.001). Fonksiyonel kabızlığı olan hastalar arasında 266 (%55.5) kişi bu çalışmadan önce tedavi almamışken, 217 (%44.5) kişi tedavi almıştı. Tedavi gören ve görmeyen hastalar arasında hemoglobin, trombosit sayısı, kalsiyum, magnezyum, sodyum ve klorür değerlerinde anlamlı bir fark yoktu.

Sonuç: Fonksiyonel konstipasyon hastalarının magnezyum ve diğer elektrolit düzeylerinin normal popülasyondan farklı olmadığı saptanmıştır. Yaygın görülen fonksiyonel konstipasyonun daha kapsamlı biçimde anlaşılabilmesi için ileriye dönük prospektif çalışmalara ihtiyaç vardır.

Anahtar Kelimeler

elektrolitler , fonksiyonel kabızlık , magnezyum

Etik Beyan

Bu çalışma, Kayseri Şehir Hastanesi Girişimsel Olmayan Klinik Araştırmalar Etik Kurulu tarafından onaylanmıştır (Tarih: 28.01.2025, Karar numarası: 300).

Kaynakça

• Geus A, Koppen I, Flint R, Benninga M, Tabbers M. An update of pharmacological management in children with functional constipation. Paediatr Drugs. 2023;25(3):343–358.
• Levy E, Lemmens R, Vandenplas Y, Devreker T. Functional constipation in children: challenges and solutions. Pediatric Health Med Ther. 2017;8:19–27.
• Dupont C, Constant F, Imbert A, Hébert G, Zourabichvili O, Kapel N. Time to treatment response of a magnesium- and sulphate-rich natural mineral water in functional constipation. Nutrition. 2019;65:167–172.
• Dupont C, Hébert G. Magnesium sulfate-rich natural mineral waters in the treatment of functional constipation: a review. Nutrients. 2020;12(7):2052.
• Classen M, Grunder F, Schumann S, Gontard A, Laffolie J. Constipation in children and adolescents. Dtsch Arztebl Int. 2022;119(41):697–708.
• Tran D, Sintusek P. Functional constipation in children: what physicians should know. World J Gastroenterol. 2023;29(8):1261–1288.
• Murakami K, Sasaki S, Okubo H, Takahashi Y, Hosoi Y, Itabashi M; Freshmen in Dietetic Courses Study II Group. Association between dietary fiber, water and magnesium intake and functional constipation among young Japanese women. Eur J Clin Nutr. 2007;61(5):616–622.
• Hyams J, Lorenzo C, Saps M, Shulman R, Staiano A, Tilburg M. Functional disorders: children and adolescents. Gastroenterology. 2016;150(6):1456–1468.
• Lewis S, Heaton K. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920–924.
• Vu M, Nouwens M, Biemond I, Lamers C, Masclee A. The osmotic laxative magnesium sulphate activates the ileal brake. Aliment Pharmacol Ther. 2000;14(5):587–595.
• Ikarashi N, Ushiki T, Mochizuki T, et al. Effects of magnesium sulphate administration on aquaporin 3 in rat gastrointestinal tract. Biol Pharm Bull. 2011;34(2):238–242.
• Dupont C, Campagne A, Constant F. Efficacy and safety of a magnesium sulfate-rich natural mineral water for patients with functional constipation. Clin Gastroenterol Hepatol. 2014;12(8):1280–1287.
• Benninga M, Vandenplas Y. The magnesium-rich formula for functional constipation in infants: a randomized comparator-controlled study. Pediatr Gastroenterol Hepatol Nutr. 2019;22(3):270–281.
• Knowles C, Farrugia G. Gastrointestinal neuromuscular pathology in chronic constipation. Best Pract Res Clin Gastroenterol. 2011;25(1):43–57.
• Kishi K, Kamizaki M, Kaji N, Iino S, Hori M. A close relationship between networks of interstitial cells of Cajal and gastrointestinal transit in vivo. Front Pharmacol. 2020;11:587453.
• Hassanein S, Deifallah S, Bastawy H. Efficacy of oral magnesium therapy in the treatment of chronic constipation in spastic cerebral palsy children: a randomized controlled trial. World J Pediatr. 2021;17(1):92–98.
• Bothe G, Coh A, Auinger A. Efficacy and safety of a natural mineral water rich in magnesium and sulphate for bowel function: a double-blind, randomized, placebo-controlled study. Eur J Nutr. 2017;56(2):491–499.
• Schelling JR. Fatal hypermagnesemia. Clin Nephrol. 2000;53(1):61–65.
• Yamamoto M, Nakayama T. A comparative study of the communication of drug safety information by governmental agencies in Japan and Western countries: the case of asthma medications. Ther Innov Regul Sci. 2008;42(6):583–596.
• Kutsal E, Aydemir C, Eldes N, et al. Severe hypermagnesemia as a result of excessive cathartic ingestion in a child without renal failure. Pediatr Emerg Care. 2007;23(8):570–572.
• Tatsuki M, Miyazawa R, Tomomasa T, Ishige T, Nakazawa T, Arakawa H. Serum magnesium concentration in children with functional constipation treated with magnesium oxide. World J Gastroenterol. 2011;17(6):779–783.